These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3256254)

  • 21. Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice.
    Hori J; Yamagami S; Obata H; Tsuru T; Isobe M
    Transplant Proc; 1996 Jun; 28(3):1990-1. PubMed ID: 8658970
    [No Abstract]   [Full Text] [Related]  

  • 22. Modulation of murine alloantigens by tissue culture and phytomitogens.
    Lifton J; Sigmon E; DeWolf WC; Park KI; Miller J
    Transplant Proc; 1977 Mar; 9(1):657-60. PubMed ID: 141135
    [No Abstract]   [Full Text] [Related]  

  • 23. Isograft and allograft control studies for murine cardiac transplantation.
    Smith JA; Mottram PL; Mirisklavos A; Mason A; Dumble LJ; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1039-42. PubMed ID: 3547848
    [No Abstract]   [Full Text] [Related]  

  • 24. Spleen cell transplantation in mice: influence of non-H-2 M locus on graft-vs.-host and host-vs.-graft reactions.
    Huber B; Peña-Martinez J; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1373-5. PubMed ID: 4149546
    [No Abstract]   [Full Text] [Related]  

  • 25. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
    de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
    Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice.
    Sonoda Y; Ksander B; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1374-6. PubMed ID: 8442147
    [No Abstract]   [Full Text] [Related]  

  • 27. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M; Ihara A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of ultraviolet irradiation on the localization of syngeneic and allogeneic lymphoid cells and on alloimmunogenicity.
    Milton JD
    Immunology; 1981 Oct; 44(2):281-7. PubMed ID: 7298068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice.
    Lu X; Zhou L; Chen S
    Transplant Proc; 2004 Oct; 36(8):2429-31. PubMed ID: 15561269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
    Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
    Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
    [No Abstract]   [Full Text] [Related]  

  • 31. Occurrence of tumor antigen pRL1a specific CD8 T cells in spleen cells from syngeneic BALB/c, semiallogeneic (BALB/c x C57BL/6)F1 and allogeneic C57BL/6 mice.
    Hata H; Uenaka A; Takada I; Kenjo A; Takahashi M; Ono T; Fujita T; Nakayama E
    Int J Oncol; 2002 May; 20(5):1019-25. PubMed ID: 11956599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful transplantation of chimeric allogeneic-autologous cultured epithelium.
    Rouabhia M; Germain L; Bergeron J; Auger FA
    Transplant Proc; 1994 Dec; 26(6):3361-2. PubMed ID: 7998174
    [No Abstract]   [Full Text] [Related]  

  • 33. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
    Toubai T; Tanaka J; Nishihira J; Ohkawara T; Hirate D; Kondo N; Tone S; Shono Y; Ibata M; Sugita J; Kato N; Miura Y; Iwao N; Ota S; Imamura M
    Transpl Immunol; 2006 Aug; 16(2):117-24. PubMed ID: 16860715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of syngeneic and allogeneic grafted bone in transgenic mice.
    Nishida Y; Kondo S; Miura Y; Iwata H; Isobe K
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1081-5. PubMed ID: 8250865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inactivation of allogeneic stem cells by lymphocytes identical as regards the H2 system of tissue compatibility].
    Petrov RV; Egorov IK; Seslavina LS; Panteleev EI; Egorova OS
    Dokl Akad Nauk SSSR; 1974; 219(6):1489-91. PubMed ID: 4155671
    [No Abstract]   [Full Text] [Related]  

  • 39. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
    Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
    [No Abstract]   [Full Text] [Related]  

  • 40. [Morphometric study of the spleen in C57BL strain mice during pregnancy with syngeneic or allogeneic embryos].
    Kolesnikov SI; Morozova LM
    Tsitol Genet; 1979; 13(5):351-3. PubMed ID: 516160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.